Regulation of NMDA-stimulated [14C]GABA and [3H]acetylcholine release by striatal glutamate and dopamine receptors

被引:28
作者
Hanania, T [1 ]
Johnson, KM [1 ]
机构
[1] Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA
关键词
ACh release; dopamine; GABA release; glutamate; NMDA; striatum; Parkinson's disease;
D O I
10.1016/S0006-8993(99)01869-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Striatal function is heavily influenced by glutamatergic and dopaminergic afferent input. To ultimately better understand how the N-methyl-D-aspartate (NMDA) antagonist, phencyclidine (PCP), alters striatal function, we sought to determine how NMDA receptor function is influenced by activation of other glutamatergic receptors and by dopaminergic receptors. To this end, we used NMDA-stimulated efflux of [C-14]GABA and [H-3]acetylcholine (ACh) from striatal slices to assess the influence of these receptors on NMDA function. NMDA-stimulated [C-14]GABA release was more sensitive to NMDA and glycine antagonists than was [H-3]ACh release, suggesting that different NMDA receptors regulate the release of these neurotransmitters. Furthermore, NMDA-stimulated [H-3]ACh release was inhibited by a D-2 receptor mechanism whereas NMDA-stimulated [C-14]GABA release was enhanced by D-1 receptor activation. NMDA and (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid hydrobromide (AMPA) interact additively to evoke [H-3]ACh release, and synergistically to evoke [C-14]GABA release. An additive effect of NMDA and kainate (KA) was found on [C-14]GABA release, but NMDA and KA. acted in a less than additive manner in evoking [H-3]ACh release. KA-stimulated [H-3]ACh release was largely blocked by NMDA antagonists, suggesting mediation through activation of NMDA receptors, probably secondary to KA-induced glutamate release. A selective group II metabotropic receptor agonist inhibited NMDA-stimulated [C-14]GABA and [H-3]ACh release. On the other hand, NMDA-stimulated [C-14]GABA release was potentiated by activation of group I metabotropic receptors. Thus, in addition to the differential modulation by D-1- and D-2-like receptors, the release of striatal neurotransmitters by NMDA receptor activation depends on the extent to which the other glutamate receptors, both ionotropic and metabotropic, are activated. (C) 1999 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:106 / 117
页数:12
相关论文
共 50 条
[1]   THE FUNCTIONAL-ANATOMY OF BASAL GANGLIA DISORDERS [J].
ALBIN, RL ;
YOUNG, AB ;
PENNEY, JB .
TRENDS IN NEUROSCIENCES, 1989, 12 (10) :366-375
[2]   Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes [J].
Avenet, P ;
Leonardon, J ;
Besnard, F ;
Graham, D ;
Depoortere, H ;
Scatton, B .
NEUROSCIENCE LETTERS, 1997, 223 (02) :133-136
[3]  
BERNARD V, 1997, J NEUROSCI, V17, P812
[4]   NEUROMODULATORY ACTIONS OF DOPAMINE IN THE NEOSTRIATUM ARE DEPENDENT UPON THE EXCITATORY AMINO-ACID RECEPTOR SUBTYPES ACTIVATED [J].
CEPEDA, C ;
BUCHWALD, NA ;
LEVINE, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (20) :9576-9580
[5]   METABOTROPIC GLUTAMATE RECEPTORS MODULATE N-METHYL-D-ASPARTATE RECEPTOR FUNCTION IN NEOSTRIATAL NEURONS [J].
COLWELL, CS ;
LEVINE, MS .
NEUROSCIENCE, 1994, 61 (03) :497-507
[6]   NAPHTHALENE-2,3-DICARBOXALDEHYDE CYANIDE ION - A RATIONALLY DESIGNED FLUOROGENIC REAGENT FOR PRIMARY AMINES [J].
DEMONTIGNY, P ;
STOBAUGH, JF ;
GIVENS, RS ;
CARLSON, RG ;
SRINIVASACHAR, K ;
STERNSON, LA ;
HIGUCHI, T .
ANALYTICAL CHEMISTRY, 1987, 59 (08) :1096-1101
[7]  
EMSON PC, 1993, PROG BRAIN RES, V99, P155
[8]   KAINIC ACID STIMULATES EXCITATORY AMINO-ACID NEUROTRANSMITTER RELEASE AT PRE-SYNAPTIC RECEPTORS [J].
FERKANY, JW ;
ZACZEK, R ;
COYLE, JT .
NATURE, 1982, 298 (5876) :757-759
[9]   SINGLE K+ CHANNELS ACTIVATED BY D2-DOPAMINE RECEPTORS IN ACUTELY DISSOCIATED NEURONS FROM RAT CORPUS STRIATUM [J].
FREEDMAN, JE ;
WEIGHT, FF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (10) :3618-3622
[10]   N-METHYL-D-ASPARTATE ANTAGONISTS IN THE TREATMENT OF PARKINSONS-DISEASE [J].
GREENAMYRE, JT ;
OBRIEN, CF .
ARCHIVES OF NEUROLOGY, 1991, 48 (09) :977-981